Sant Pau - Institut de Recerca

Main lines of research

Oncology

New diagnostic methods based on the identification and visualization of molecular targets employing metabolic mechanisms, receptor systems, hypoxia, angiogenesis and apoptosis.
New applications for sentinel node detection and radioguided surgery models.

Cardiovascular research

New methods for non-invasive assessment of ischaemic heart disease and heart failure.
Cardiovascular functional studies.
New methods for assessing cardiac innervation.

Functional Neuroimaging

Development of new functional imaging methods for evaluating neurodegenerative diseases (Parkinson, Parkinson-Plus, Alzheimer, MCI).
Dopaminergic system studies using IBZM and Datscan.

Challenges

Introduce new technologies to clinical research (given that imaging techniques are evolving very rapidly towards multimodal systems that integrate biological, molecular, anatomical and functional information in a single examination) and include these technologies, mainly PET/CT and PET/MR, in the group and hospital’s research activities.

New Molecular Imaging Techniques

Develop new hybrid molecular imaging technologies, mainly PET/CT and PET/MR, building on pre-clinical and clinical molecular imaging models developed using SPECT and conventional nuclear medicine technologies.

PET Imaging Biomarkers

Develop new PET radioactive tracers to be used as biomarkers in new imaging tecnologies building on our experience with radioactive tracers to view in vivo diagnostic and therapeutic targets.

Group coordination

FLOTATS GIRALT, ALBERT FGS
aflotats@santpau.cat

Members

Calls Calahorro, Marc FGS
Camacho Marti, Maria Del Valle FGS
Castejon Echevarne, Simona FGS
Duch Renom, Joan FGS
Fernandez Leon, Alejandro FGS
Soldevila Lozano, Cristina FGS
Stefaneli Normandi, Patricia FGS
Torres Quintana, Maria Paula FGS
Velasco Nuño, Monica FGS

Publications 2022

(JIF 2022)

Abouzian S, Camacho V, Sabate A, Stefaneli P, Sizova M, Gich I, Lopez D, Duch J, Fernandez A, Estorch M, Carrio I, Flotats A. Audiovisual intervention alleviates anxiety of patients during PET/CT imaging. NUKLEARMEDIZIN-NUCLEAR MEDICINE. 2022; 61(04). DOI:10.1055/a-1759-4062. PMID:35931063. IF:1,5 (Q4/9D). Document type: Article.
Arbizu J, Perez JG, Hilario A, Grande AG, Rubi S, Camacho V. Update on the diagnosis of encephalitis. Revista Espanola de Medicina Nuclear e Imagen Molecular. 2022; 41(4). DOI:10.1016/j.remnie.2022.05.003. PMID:35701317. IF:1,2 (Q4/9D). Document type: Article.
Camps P, McCabe J, Marti J, Giannotti N, Fernandez A, McNulty JP, Baron JC, Barry M, Coutts SB, Cronin S, Delgado R, Dolan E, Foley S, Guasch M, Guisado D, Harbison JA, Horgan G, Kavanagh EC, Marnane M, Martinez A, McDonnell C, Sharma VK, Williams D, Connell MO, Murphy S, Prats L, Kelly PJ. Association of Plaque Inflammation With Stroke Recurrence in Patients With Unproven Benefit From Carotid Revascularization. NEUROLOGY. 2022; 99(2). DOI:10.1212/WNL.0000000000200525. PMID:35418461. IF:9,9 (Q1/1D). Document type: Article.
Casasayas M, Garcia J, Gomez B, Medina V, Fernandez A, Quer M, Leon X. Low skeletal muscle mass assessed directly from the 3rd cervical vertebra can predict pharyngocutaneous fistula risk after total laryngectomy in the male population. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(2). DOI:10.1007/s00405-021-07127-3. PMID:34665301. IF:2,6 (Q2/3D). Document type: Article.
Etminani K, Soliman A, Davidsson A, Chang JR, Martinez B, Byttner S, Camacho V, Bauckneht M, Stegeran R, Ressner M, Agudelo M, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Nicastro N, Frisoni GB, Lemstra AW, van BNM, Pilotto A, Padovani A, Morbelli S, Aarsland D, Nobili F, Garibotto V, Ochoa M. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022; 49(2). DOI:10.1007/s00259-021-05483-0. PMID:34328531. IF:9,1 (Q1/1D). Document type: Article.
Gomez A, Camacho V. Early phase amyloid PET or “two birds with one Stone “. Revista Espanola de Medicina Nuclear e Imagen Molecular. 2022; 41(4). DOI:10.1016/j.remn.2022.06.001. PMID:35760462. IF:1,2 (Q4/9D). Document type: Editorial material.
Heeman F, Moscoso A, Camacho V, van M, Grothe MJ, Lin L, Mainta I, Ribaldi F, Devous MD, SR, Pontecorvo MJ, Frisoni GB, Garibotto V, Schöll M. Relationship between [18F]flortaucipir PET visual patterns and neurodegeneration. Alzheimers & Dementia. 2022; 18:e067143. DOI:10.1002/alz.067143. IF:14 (Q1/1D). Document type: Note.
López DA, Carrió I, Flotats A. Digital PET vs Analog PET: Clinical Implications?. SEMINARS IN NUCLEAR MEDICINE. 2022; 52(3). DOI:10.1053/j.semnuclmed.2021.10.004. PMID:34836617. IF:4,9 (Q1/2D). Document type: Review.
Moscoso A, Heeman F, Camacho V, van M, Grothe MJ, Lin L, Mainta I, Ribaldi F, Devous MD, SR, Pontecorvo MJ, Frisoni GB, Garibotto V, Schöll M. Prevalence and longitudinal clinical outcomes of negative, moderate, and advanced 18F-flortaucipir PET visual patterns in aging and Alzheimer’s disease. Alzheimers & Dementia. 2022; 18:e068009. DOI:10.1002/alz.068009. IF:14 (Q1/1D). Document type: Note.
Ona G, Sampedro F, Romero S, Valle M, Camacho V, Migliorelli C, Mananas MA, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, Riba J. The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2022; 25(1)DOI:10.1093/ijnp/pyab063. PMID:34537829. IF:4,8 (Q1/3D). Document type: Article.
Puig N, Camps P, Camacho M, Aguilera A, Jimenez F, Fernandez A, Marin R, Marti J, Sanchez JL, Jimenez E, Benitez S. Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke. Translational Stroke Research. 2022; 13(5). DOI:10.1007/s12975-022-01002-x. PMID:35237947. IF:6,9 (Q1/1D). Document type: Article.
Sizova M, Camacho V, Sampedro F, Sabate A, Abouzian S, Stefaneli P, Duch J, Fernandez A, Lopez DA, Estorch M, Carrio I, Flotats A. Brain metabolic changes in patients with disseminated malignant melanoma under immunotherapy. MELANOMA RESEARCH. 2022; 32(5). DOI:10.1097/CMR.0000000000000835. PMID:35703175. IF:2,2 (Q3/7D). Document type: Article.
Soliman A, Chang JR, Etminani K, Byttner S, Davidsson A, Martinez B, Camacho V, Bauckneht M, Stegeran R, Ressner M, Agudelo M, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Nicastro N, Frisoni GB, Lemstra AW, van BNM, Pilotto A, Padovani A, Morbelli S, Aarsland D, Nobili F, Garibotto V, Ochoa M, Alzheimer’s Dis Neuroimaging I. Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model. BMC Medical Informatics and Decision Making. 2022; 22(SUPPL 6):318. DOI:10.1186/s12911-022-02054-7. PMID:36476613. IF:3,5 (Q3/6D). Document type: Article.
Tian M, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Zhou R, Hou HF, Dou XF, Jin CT, Zuo CT, Zhang H, Mol Imaging TA. International consensus on the use of tau PET imaging agent F-18-flortaucipir in Alzheimer’s disease. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022; 49(3). DOI:10.1007/s00259-021-05673-w. PMID:34978595. IF:9,1 (Q1/1D). Document type: Article.

Publications 2021

Bauckneht M, Chincarini A, Brendel M, Rominger A, Beyer L, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, Berckel BNM, Pilotto A, Padovani A, Ochoa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Pardini M, Donegani MI, Raffa S, Miceli A, Sambuceti G, Aarsland D, Nobili F, Morbelli S. Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project. Alzheimers & Dementia. 2021; 17(8). DOI:10.1002/alz.12294. PMID:33528089. IF:16,655.
Bejanin A, Iulita MF, Vilaplana E, Carmona M, Benejam B, Videla L, Barroeta I, Fernandez S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Gimenez S, Gonzalez S, Munoz L, Padilla C, Aranha MR, Estelles T, Illan I, Belbin O, Camacho V, Wilson LR, Annus T, Osorio RS, Videla S, Lehmann S, Holland AJ, Zetterberg H, et al. [Alcolea D, Clarimon J, Blesa R, Lleo A, Fortea J]. Association of Apolipoprotein E epsilon 4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome. JAMA Neurology. 2021; 78(8). DOI:10.1001/jamaneurol.2021.1893. PMID:34228042. IF:29,907.
Fuentes F, Lopez DA, Flotats A, Camacho V, Sizova M, Abouzian S, Duch J, Fernandez A, Estorch M, Carrio I. Digital versus analog PET/CT in patients with known or suspected liver metastases. NUCLEAR MEDICINE COMMUNICATIONS. 2021; 42(4). DOI:10.1097/MNM.0000000000001341. PMID:33306635. IF:1,698.
Hirschfeld CB, Dondi M, Pascual TNB, Mercuri M, Vitola J, Karthikeyan G, Better N, Mahmarian JJ, Bouyoucef SE, Hee-Seung Bom H, Lele V, Magboo VPC, Alexánderson E, Allam AH, Al-Mallah MH, Flotats A, Jerome S, Kaufmann PA, Luxenburg O, Underwood SR, Rehani MM, Vassileva J, Paez D, Einstein AJ; INCAPS Investigators Group. Worldwide Diagnostic Reference Levels for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Findings From INCAPS. JACC-Cardiovascular Imaging. 2021;14(3):657-665. DOI:10.1016/j.jcmg.2020.06.029. PMID: 32828783. IF:16,051.
Hirschfeld CB, Mercuri M, Pascual TNB, Karthikeyan G, Vitola JV, Mahmarian JJ, Better N, Bouyoucef SE, Bom HHS, Lele V, Magboo VPC, Alexanderson E, Allam AH, Al MH, Dorbala S, Flotats A, Jerome S, Kaufmann PA, Luxenburg O, Shaw LJ, Underwood SR, Rehani MM, Paez D, Dondi M, Einstein AJ. Worldwide Variation in the Use of Nuclear Cardiology Camera Technology, Reconstruction Software, and Imaging Protocols. JACC-Cardiovascular Imaging. 2021; 14(9). DOI:10.1016/j.jcmg.2020.11.011. PMID:33454257. IF:16,051.
Lleo A, Zetterberg H, Pegueroles J, Karikari TK, Carmona M, Ashton NJ, Montal V, Barroeta I, Lantero J, Videla L, Altuna M, Benejam B, Fernandez S, Valldeneu S, Garzon D, Bejanin A, Iulita MF, Camacho V, Medrano S, Belbin O, Clarimon J, Lehmann S, Alcolea D, Blesa R, Blennow K, Fortea J. Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome. Nature Communications. 2021; 12(1):4304. DOI:10.1038/s41467-021-24319-x. PMID:34262030. IF:17,694.
McCabe JJ, Camps P, Giannotti N, McNulty JP, Coveney S, Murphy S, Barry M, Harbison J, Cronin S, Williams D, Horgan G, Dolan E, Cassidy T, McDonnell C, Kavanagh E, Foley S, Collins S, O’Connell M, Fernandez A, Delgado R, Marnane M, Marti J, Kelly PJ. Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years. NEUROLOGY. 2021; 97(23). DOI:10.1212/WNL.0000000000012909. PMID:34610991. IF:11,800.
Moya P, Leon AF, Corica ME, Marti VC, Lopez DA, Castellvi I, Corominas H. “The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica”. PLoS One. 2021; 16(9):e0255131. DOI:10.1371/journal.pone.0255131. PMID:34559822. IF:3,752.
Ovcaricek PP, Giovanella L, Gasset IC, Hindie E, Huellner MW, Luster M, Piccardo A, Weber T, Talbot JN, Verburg FA. The EANM practice guidelines for parathyroid imaging. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021; 48(9). DOI:10.1007/s00259-021-05334-y. PMID:33839893. IF:10,057.
Pegueroles J, Montal V, Bejanin A, Vilaplana E, Aranha M, Santos MA, Alcolea D, Carrio I, Camacho V, Blesa R, Lleo A, Fortea J. AMYQ: An index to standardize quantitative amyloid load across PET tracers. Alzheimers & Dementia. 2021; 17(9). DOI:10.1002/alz.12317. PMID:33797846. IF:16,655.
Pons G, Abdelfattah U, Sarria J, Duch J, Masia J. Reverse Lymph Node Mapping Using Indocyanine Green Lymphography: A Step Forward in Minimizing Donor-Site Morbidity in Vascularized Lymph Node Transfer. PLASTIC AND RECONSTRUCTIVE SURGERY. 2021; 147(2). DOI:10.1097/PRS.0000000000007585. PMID:33565822. IF:5,169.
Sampedro F, Marin J, Martinez S, Camacho V, Lopez DA, Pagonabarraga J, Kulisevsky J. Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson’s disease. NEUROBIOLOGY OF AGING. 2021; 97. DOI:10.1016/j.neurobiolaging.2020.10.016. PMID:33212336. IF:5,133.
Sampedro F, Stantonyonge N, Martínez-Horta S, Nan N, Camacho V, Chico A. Increased cerebral FDG-PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia. JOURNAL OF NEUROENDOCRINOLOGY. 2021;33(1):e12910. DOI:10.1111/jne.12910. PMID: 33176042. IF:3,870.
Tian M, Watanabe Y, Kang KW, Murakami K, Chiti A, Carrio I, Civelek AC, Feng JH, Zhu YK, Zhou R, Wu S, Zhu JM, Ding Y, Zhang K, Zhang H, Mol Imaging TA. International consensus on the use of [F-18]-FDG PET/CT in pediatric patients affected by epilepsy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021; 48(12). DOI:10.1007/s00259-021-05524-8. PMID:34453559. IF:10,057.

Introduction

Main lines of research

Oncology

New diagnostic methods based on the identification and visualization of molecular targets employing metabolic mechanisms, receptor systems, hypoxia, angiogenesis and apoptosis.
New applications for sentinel node detection and radioguided surgery models.

Cardiovascular research

New methods for non-invasive assessment of ischaemic heart disease and heart failure.
Cardiovascular functional studies.
New methods for assessing cardiac innervation.

Functional Neuroimaging

Development of new functional imaging methods for evaluating neurodegenerative diseases (Parkinson, Parkinson-Plus, Alzheimer, MCI).
Dopaminergic system studies using IBZM and Datscan.

Challenges

Introduce new technologies to clinical research (given that imaging techniques are evolving very rapidly towards multimodal systems that integrate biological, molecular, anatomical and functional information in a single examination) and include these technologies, mainly PET/CT and PET/MR, in the group and hospital’s research activities.

New Molecular Imaging Techniques

Develop new hybrid molecular imaging technologies, mainly PET/CT and PET/MR, building on pre-clinical and clinical molecular imaging models developed using SPECT and conventional nuclear medicine technologies.

PET Imaging Biomarkers

Develop new PET radioactive tracers to be used as biomarkers in new imaging tecnologies building on our experience with radioactive tracers to view in vivo diagnostic and therapeutic targets.

Team

Group coordination

FLOTATS GIRALT, ALBERT FGS
aflotats@santpau.cat

Members

Scientific output

Publications 2022

(JIF 2022)

Abouzian S, Camacho V, Sabate A, Stefaneli P, Sizova M, Gich I, Lopez D, Duch J, Fernandez A, Estorch M, Carrio I, Flotats A. Audiovisual intervention alleviates anxiety of patients during PET/CT imaging. NUKLEARMEDIZIN-NUCLEAR MEDICINE. 2022; 61(04). DOI:10.1055/a-1759-4062. PMID:35931063. IF:1,5 (Q4/9D). Document type: Article.
Arbizu J, Perez JG, Hilario A, Grande AG, Rubi S, Camacho V. Update on the diagnosis of encephalitis. Revista Espanola de Medicina Nuclear e Imagen Molecular. 2022; 41(4). DOI:10.1016/j.remnie.2022.05.003. PMID:35701317. IF:1,2 (Q4/9D). Document type: Article.
Camps P, McCabe J, Marti J, Giannotti N, Fernandez A, McNulty JP, Baron JC, Barry M, Coutts SB, Cronin S, Delgado R, Dolan E, Foley S, Guasch M, Guisado D, Harbison JA, Horgan G, Kavanagh EC, Marnane M, Martinez A, McDonnell C, Sharma VK, Williams D, Connell MO, Murphy S, Prats L, Kelly PJ. Association of Plaque Inflammation With Stroke Recurrence in Patients With Unproven Benefit From Carotid Revascularization. NEUROLOGY. 2022; 99(2). DOI:10.1212/WNL.0000000000200525. PMID:35418461. IF:9,9 (Q1/1D). Document type: Article.
Casasayas M, Garcia J, Gomez B, Medina V, Fernandez A, Quer M, Leon X. Low skeletal muscle mass assessed directly from the 3rd cervical vertebra can predict pharyngocutaneous fistula risk after total laryngectomy in the male population. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2022; 279(2). DOI:10.1007/s00405-021-07127-3. PMID:34665301. IF:2,6 (Q2/3D). Document type: Article.
Etminani K, Soliman A, Davidsson A, Chang JR, Martinez B, Byttner S, Camacho V, Bauckneht M, Stegeran R, Ressner M, Agudelo M, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Nicastro N, Frisoni GB, Lemstra AW, van BNM, Pilotto A, Padovani A, Morbelli S, Aarsland D, Nobili F, Garibotto V, Ochoa M. A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer’s disease, and mild cognitive impairment using brain 18F-FDG PET. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022; 49(2). DOI:10.1007/s00259-021-05483-0. PMID:34328531. IF:9,1 (Q1/1D). Document type: Article.
Gomez A, Camacho V. Early phase amyloid PET or “two birds with one Stone “. Revista Espanola de Medicina Nuclear e Imagen Molecular. 2022; 41(4). DOI:10.1016/j.remn.2022.06.001. PMID:35760462. IF:1,2 (Q4/9D). Document type: Editorial material.
Heeman F, Moscoso A, Camacho V, van M, Grothe MJ, Lin L, Mainta I, Ribaldi F, Devous MD, SR, Pontecorvo MJ, Frisoni GB, Garibotto V, Schöll M. Relationship between [18F]flortaucipir PET visual patterns and neurodegeneration. Alzheimers & Dementia. 2022; 18:e067143. DOI:10.1002/alz.067143. IF:14 (Q1/1D). Document type: Note.
López DA, Carrió I, Flotats A. Digital PET vs Analog PET: Clinical Implications?. SEMINARS IN NUCLEAR MEDICINE. 2022; 52(3). DOI:10.1053/j.semnuclmed.2021.10.004. PMID:34836617. IF:4,9 (Q1/2D). Document type: Review.
Moscoso A, Heeman F, Camacho V, van M, Grothe MJ, Lin L, Mainta I, Ribaldi F, Devous MD, SR, Pontecorvo MJ, Frisoni GB, Garibotto V, Schöll M. Prevalence and longitudinal clinical outcomes of negative, moderate, and advanced 18F-flortaucipir PET visual patterns in aging and Alzheimer’s disease. Alzheimers & Dementia. 2022; 18:e068009. DOI:10.1002/alz.068009. IF:14 (Q1/1D). Document type: Note.
Ona G, Sampedro F, Romero S, Valle M, Camacho V, Migliorelli C, Mananas MA, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, Riba J. The Kappa Opioid Receptor and the Sleep of Reason: Cortico-Subcortical Imbalance Following Salvinorin-A. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY. 2022; 25(1)DOI:10.1093/ijnp/pyab063. PMID:34537829. IF:4,8 (Q1/3D). Document type: Article.
Puig N, Camps P, Camacho M, Aguilera A, Jimenez F, Fernandez A, Marin R, Marti J, Sanchez JL, Jimenez E, Benitez S. Plasma sICAM-1 as a Biomarker of Carotid Plaque Inflammation in Patients with a Recent Ischemic Stroke. Translational Stroke Research. 2022; 13(5). DOI:10.1007/s12975-022-01002-x. PMID:35237947. IF:6,9 (Q1/1D). Document type: Article.
Sizova M, Camacho V, Sampedro F, Sabate A, Abouzian S, Stefaneli P, Duch J, Fernandez A, Lopez DA, Estorch M, Carrio I, Flotats A. Brain metabolic changes in patients with disseminated malignant melanoma under immunotherapy. MELANOMA RESEARCH. 2022; 32(5). DOI:10.1097/CMR.0000000000000835. PMID:35703175. IF:2,2 (Q3/7D). Document type: Article.
Soliman A, Chang JR, Etminani K, Byttner S, Davidsson A, Martinez B, Camacho V, Bauckneht M, Stegeran R, Ressner M, Agudelo M, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Nicastro N, Frisoni GB, Lemstra AW, van BNM, Pilotto A, Padovani A, Morbelli S, Aarsland D, Nobili F, Garibotto V, Ochoa M, Alzheimer’s Dis Neuroimaging I. Adopting transfer learning for neuroimaging: a comparative analysis with a custom 3D convolution neural network model. BMC Medical Informatics and Decision Making. 2022; 22(SUPPL 6):318. DOI:10.1186/s12911-022-02054-7. PMID:36476613. IF:3,5 (Q3/6D). Document type: Article.
Tian M, Civelek AC, Carrio I, Watanabe Y, Kang KW, Murakami K, Garibotto V, Prior JO, Barthel H, Zhou R, Hou HF, Dou XF, Jin CT, Zuo CT, Zhang H, Mol Imaging TA. International consensus on the use of tau PET imaging agent F-18-flortaucipir in Alzheimer’s disease. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2022; 49(3). DOI:10.1007/s00259-021-05673-w. PMID:34978595. IF:9,1 (Q1/1D). Document type: Article.

Publications 2021

Bauckneht M, Chincarini A, Brendel M, Rominger A, Beyer L, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, Berckel BNM, Pilotto A, Padovani A, Ochoa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Pardini M, Donegani MI, Raffa S, Miceli A, Sambuceti G, Aarsland D, Nobili F, Morbelli S. Associations among education, age, and the dementia with Lewy bodies (DLB) metabolic pattern: A European-DLB consortium project. Alzheimers & Dementia. 2021; 17(8). DOI:10.1002/alz.12294. PMID:33528089. IF:16,655.
Bejanin A, Iulita MF, Vilaplana E, Carmona M, Benejam B, Videla L, Barroeta I, Fernandez S, Altuna M, Pegueroles J, Montal V, Valldeneu S, Gimenez S, Gonzalez S, Munoz L, Padilla C, Aranha MR, Estelles T, Illan I, Belbin O, Camacho V, Wilson LR, Annus T, Osorio RS, Videla S, Lehmann S, Holland AJ, Zetterberg H, et al. [Alcolea D, Clarimon J, Blesa R, Lleo A, Fortea J]. Association of Apolipoprotein E epsilon 4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome. JAMA Neurology. 2021; 78(8). DOI:10.1001/jamaneurol.2021.1893. PMID:34228042. IF:29,907.
Fuentes F, Lopez DA, Flotats A, Camacho V, Sizova M, Abouzian S, Duch J, Fernandez A, Estorch M, Carrio I. Digital versus analog PET/CT in patients with known or suspected liver metastases. NUCLEAR MEDICINE COMMUNICATIONS. 2021; 42(4). DOI:10.1097/MNM.0000000000001341. PMID:33306635. IF:1,698.
Hirschfeld CB, Dondi M, Pascual TNB, Mercuri M, Vitola J, Karthikeyan G, Better N, Mahmarian JJ, Bouyoucef SE, Hee-Seung Bom H, Lele V, Magboo VPC, Alexánderson E, Allam AH, Al-Mallah MH, Flotats A, Jerome S, Kaufmann PA, Luxenburg O, Underwood SR, Rehani MM, Vassileva J, Paez D, Einstein AJ; INCAPS Investigators Group. Worldwide Diagnostic Reference Levels for Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging: Findings From INCAPS. JACC-Cardiovascular Imaging. 2021;14(3):657-665. DOI:10.1016/j.jcmg.2020.06.029. PMID: 32828783. IF:16,051.
Hirschfeld CB, Mercuri M, Pascual TNB, Karthikeyan G, Vitola JV, Mahmarian JJ, Better N, Bouyoucef SE, Bom HHS, Lele V, Magboo VPC, Alexanderson E, Allam AH, Al MH, Dorbala S, Flotats A, Jerome S, Kaufmann PA, Luxenburg O, Shaw LJ, Underwood SR, Rehani MM, Paez D, Dondi M, Einstein AJ. Worldwide Variation in the Use of Nuclear Cardiology Camera Technology, Reconstruction Software, and Imaging Protocols. JACC-Cardiovascular Imaging. 2021; 14(9). DOI:10.1016/j.jcmg.2020.11.011. PMID:33454257. IF:16,051.
Lleo A, Zetterberg H, Pegueroles J, Karikari TK, Carmona M, Ashton NJ, Montal V, Barroeta I, Lantero J, Videla L, Altuna M, Benejam B, Fernandez S, Valldeneu S, Garzon D, Bejanin A, Iulita MF, Camacho V, Medrano S, Belbin O, Clarimon J, Lehmann S, Alcolea D, Blesa R, Blennow K, Fortea J. Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer’s disease in adults with Down syndrome. Nature Communications. 2021; 12(1):4304. DOI:10.1038/s41467-021-24319-x. PMID:34262030. IF:17,694.
McCabe JJ, Camps P, Giannotti N, McNulty JP, Coveney S, Murphy S, Barry M, Harbison J, Cronin S, Williams D, Horgan G, Dolan E, Cassidy T, McDonnell C, Kavanagh E, Foley S, Collins S, O’Connell M, Fernandez A, Delgado R, Marnane M, Marti J, Kelly PJ. Carotid Plaque Inflammation Imaged by PET and Prediction of Recurrent Stroke at 5 Years. NEUROLOGY. 2021; 97(23). DOI:10.1212/WNL.0000000000012909. PMID:34610991. IF:11,800.
Moya P, Leon AF, Corica ME, Marti VC, Lopez DA, Castellvi I, Corominas H. “The added value of 18f-FDG PET/CT in the assessment of onset and steroid resistant polimyalgia rheumatica”. PLoS One. 2021; 16(9):e0255131. DOI:10.1371/journal.pone.0255131. PMID:34559822. IF:3,752.
Ovcaricek PP, Giovanella L, Gasset IC, Hindie E, Huellner MW, Luster M, Piccardo A, Weber T, Talbot JN, Verburg FA. The EANM practice guidelines for parathyroid imaging. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021; 48(9). DOI:10.1007/s00259-021-05334-y. PMID:33839893. IF:10,057.
Pegueroles J, Montal V, Bejanin A, Vilaplana E, Aranha M, Santos MA, Alcolea D, Carrio I, Camacho V, Blesa R, Lleo A, Fortea J. AMYQ: An index to standardize quantitative amyloid load across PET tracers. Alzheimers & Dementia. 2021; 17(9). DOI:10.1002/alz.12317. PMID:33797846. IF:16,655.
Pons G, Abdelfattah U, Sarria J, Duch J, Masia J. Reverse Lymph Node Mapping Using Indocyanine Green Lymphography: A Step Forward in Minimizing Donor-Site Morbidity in Vascularized Lymph Node Transfer. PLASTIC AND RECONSTRUCTIVE SURGERY. 2021; 147(2). DOI:10.1097/PRS.0000000000007585. PMID:33565822. IF:5,169.
Sampedro F, Marin J, Martinez S, Camacho V, Lopez DA, Pagonabarraga J, Kulisevsky J. Extrastriatal SPECT-DAT uptake correlates with clinical and biological features of de novo Parkinson’s disease. NEUROBIOLOGY OF AGING. 2021; 97. DOI:10.1016/j.neurobiolaging.2020.10.016. PMID:33212336. IF:5,133.
Sampedro F, Stantonyonge N, Martínez-Horta S, Nan N, Camacho V, Chico A. Increased cerebral FDG-PET uptake in type 1 diabetes patients with impaired awareness of hypoglycaemia. JOURNAL OF NEUROENDOCRINOLOGY. 2021;33(1):e12910. DOI:10.1111/jne.12910. PMID: 33176042. IF:3,870.
Tian M, Watanabe Y, Kang KW, Murakami K, Chiti A, Carrio I, Civelek AC, Feng JH, Zhu YK, Zhou R, Wu S, Zhu JM, Ding Y, Zhang K, Zhang H, Mol Imaging TA. International consensus on the use of [F-18]-FDG PET/CT in pediatric patients affected by epilepsy. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2021; 48(12). DOI:10.1007/s00259-021-05524-8. PMID:34453559. IF:10,057.

ASSOCIATED GROUPS

Nuclear Medicine

Main lines of research

Oncology

Cardiovascular research

Functional Neuroimaging

Challenges

New Molecular Imaging Techniques

PET Imaging Biomarkers

Group coordination

Members

Publications 2022

Publications 2021

Main lines of research

Oncology

Cardiovascular research

Functional Neuroimaging

Challenges

New Molecular Imaging Techniques

PET Imaging Biomarkers

Group coordination

Members

Publications 2022

Publications 2021

Institut de Recerca de l’Hospital de la Santa Creu i Sant Pau